Black Swan Analysis is a provider of insightful commercialization ideas for the clients engaged in the healthcare sector.
The company delivers one-of-a-kind solutions, reliable epidemiology data, market and product overviews, and business opportunity evaluation for the clients who want to increase their capacity in producing and selling healthcare products.
Black Swan Analysis is an unrestricted resource of avant-garde solutions to the clients who want to upgrade their performance at the healthcare market. Our experience and ability to penetrate to the core of the problem enable us to produce exclusive market research reports that contain a variety of useful information including:
- Product profile
- SWOT analysis
- Growth drivers
- Market share
- Supply and demand channels
- Analysis of Competitors’ products and services
- New application areas
To ensure precise forecasting, we explore and analyze a vast variety of epidemiological and pathological data and study disease environment. Our clients can access disease epidemiology information and receive the accurate evaluation of the pricing policies of proprietors in the healthcare and pharmaceutical business.
We do not let our customers leave our company with half-baked information and weak decisions. Clients with unmet expectations are not about us. They appreciate Black Swan Analysis for adaptable solutions, proficiency, cost-effectiveness, and unique methodologies.
We help our pharmaceutical and healthcare partners recharge their capacities and increase their competitive rates. Our service algorithm is to work in close cooperation with the customer. Consistent inclusive communication helps us approach every commercial challenge expertly and invent unique business solutions.
Publications found:
186
Sort by:
Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026
US$ 6,150.00
... level across the 10-year forecast snapshot. There are a number of ... from the proprietary Epiomic patient segmentation database. To ... registries, clinical trials and epidemiology studies. All of the ... conditions on Osteoarthritis’s prevalent population. Identify sub-populations within Osteoarthritis which require ...
September 2016
64 pages
Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026
US$ 4,930.00
... information sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Rheumatoid Arthritis’s prevalent population. Identify sub-populations within Rheumatoid Arthritis which require treatment ...
September 2016
74 pages
Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026
US$ 4,930.00
... information sourced from the proprietary Epiomic patient segmentation database. To ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Hodgkin’s Lymphoma incident population. Identify sub-populations within Hodgkin’s Lymphoma which require treatment ...
September 2016
60 pages
Epiomic Epidemiology Series: Asthma Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
... level across the 10-year forecast snapshot. The main co-morbidities associated with asthma include: ... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...
August 2016
60 pages
Epiomic Epidemiology Series: Cachexia Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
... across the 10-year forecast snapshot. Key underlying pathologies linked with developing cachexia include: ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...
August 2016
46 pages
Epiomic Epidemiology Series: Sarcopenia Forecast in 13 Major Markets 2016-2026
US$ 6,382.00
... country level across the 10-year forecast snapshot. Diseases associated with sarcopenia: Obesity Type 2 ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...
August 2016
50 pages
Epiomic Epidemiology Series: HIV Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for HIV include: Impaired ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...
August 2016
42 pages
Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026
US$ 6,382.00
... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Dry Eye Syndrome’s prevalent population. Identify sub-populations within Dry Eye Syndrome which ...
July 2016
58 pages
Epiomic Epidemiology Series: Malignant Melanoma Forecast in 20 Major Markets 2016-2026
US$ 6,382.00
... symptoms and co-morbidities for Malignant Melanoma include: Family history of Malignant Melanoma Atypical nevus syndrome Exposure ... information sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...
May 2016
88 pages
Market Report for PET Imaging in Japan
US$ 9,020.00
... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the Japan market Current Japan healthcare system and reimbursement for PET imaging Market evolution and ...
April 2016
72 pages
Market Report for PET Imaging in the USA
US$ 6,400.00
... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the USA market Current USA healthcare system and reimbursement for PET imaging Market evolution ...
April 2016
139 pages
Market Report for PET Imaging in Top 5 EU Markets
US$ 16,540.00
... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the T5 EU markets Current T5 EU healthcare systems and their reimbursement schemes for PET imaging Market evolution ...
April 2016
157 pages
Epiomic Epidemiology Series: Bladder Cancer Forecast in 18 Major Markets 2016-2026
US$ 6,382.00
... Occupation Bladder infections Bladder stones Family history of bladder cancer This report is built using data and information sourced from the proprietary Epiomic patient ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data ...
April 2016
66 pages
Epiomic Epidemiology Series: Dysmenorrhea Forecast in 21 Major Markets 2016-2026
US$ 6,382.00
... of dysmenorrhea Early age at menarche Nulliparity Exercise level / fitness This report is built using data and information sourced from the proprietary Epiomic ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...
April 2016
54 pages
Epiomic Epidemiology Series: Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026
US$ 6,382.00
... co-morbidities for Brain & CNS Cancer include: Genetic susceptibility Family history of brain & CNS ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...
April 2016
66 pages
Epiomic Epidemiology Series: Glaucoma Forecast in 10 Major Markets 2016-2026
US$ 6,382.00
... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Glaucoma include: ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...
March 2016
48 pages
Epiomic Epidemiology Series: Tay-Sachs Disease Forecast in 9 Major Markets 2016-2026
US$ 6,382.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Tay-Sachs disease prevalent population. Identify sub-populations within Tay-Sachs disease which require treatment ...
March 2016
36 pages
Chronic Kidney Disease Forecast in 19 Major Markets 2016-2026
US$ 6,382.00
... Series Forecast Report on Chronic Kidney Disease (CKD) in 19 Major Markets Chronic kidney disease (CKD), also known as chronic renal disease, is characterised by progressive loss of kidney function over time. CKD is defined as persisting kidney ...
March 2016
74 pages
Epiomic Epidemiology Series: Primary Myleofibrosis Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Primary Myelofibrosis (PMF) in 8 Major Markets Primary Myelofibrosis (PMF), also known as myelofibrosis, myeloid metaplasia or chronic idiopathic ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...
March 2016
40 pages
Epiomic Epidemiology Series: Addison's Disease Forecast in 10 Major Markets 2016-2026
US$ 6,382.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Addison’s disease’s prevalent population. Identify sub-populations within Addison’s disease which require treatment ...
February 2016
38 pages
Epiomic Epidemiology Series: Behcet's Disease Forecast in 12 Major Markets 2016-2026
US$ 6,382.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Behcet’s disease’s prevalent population. Identify sub-populations within Behcet’s disease which require treatment ...
February 2016
60 pages
Epiomic Epidemiology Series: Familial Dyslipidaemia Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
... several of the main symptoms and co-morbidities of Familial Dyslipidaemia have been quantified and ... familial) Xanthomas (familial) This report is built using data and information sourced from the proprietary Epiomic ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...
February 2016
40 pages
Epiomic Epidemiology Series: Prader-Willi Syndrome Forecast in 9 Major Markets 2016-2026
US$ 6,382.00
Prader-Willi syndrome (PWS) is a genetic disease caused by the loss of ... data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient ... date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate ...
February 2016
40 pages
Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026
US$ 6,382.00
... Stomach Cancer include: History of stomach polyps or stomach lymphoma Family history of stomach cancer Family history of hereditary non-polyposis Colorectal cancer ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...
February 2016
66 pages
Epiomic Epidemiology Series: Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026
US$ 6,382.00
... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Restless Legs Syndrome’s prevalent population. Identify sub-populations within Restless Legs Syndrome which ...
January 2016
52 pages
Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026
US$ 6,382.00
... Pancreatic Cancer include: • Obesity • Diabetes • Jaundice • Pancreatitis • Gallbladder enlargement This report is built using data and information sourced from the proprietary Epiomic ... to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the ...
January 2016
54 pages
Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Ulcerative Colitis’s prevalent population. • Identify sub-populations within Ulcerative Colitis which require treatment. ...
January 2016
42 pages
Epiomic Epidemiology Series: Crohn's Disease Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
... Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Crohn’s Disease in 8 Major Markets Crohn's disease, also known as regional enteritis, is a type of chronic inflammatory bowel disease. While it may affect ... on the impact from specific co-morbid conditions on Crohn’s disease’s prevalent population. Identify sub-populations within Crohn’s disease which require treatment. Gain an understanding of the ...
January 2016
48 pages
Epiomic Epidemiology Series: Neuropathic Pain Forecast in 15 Major Markets 2016-2026
US$ 6,382.00
... Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Neuropathic Pain in 15 Major Markets Neuropathic pain is generally defined as chronic pain resulting from injury to the nervous system. Neuropathic pain is caused by other ... on the impact from specific co-morbid conditions on Neuropathic Pain’s prevalent population. Identify sub-populations within Neuropathic Pain which require treatment. Gain an understanding of the ...
January 2016
56 pages